查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974977

2026-2034年全球組織工程膠原蛋白生物材料市場規模、佔有率、趨勢和成長分析報告

Global Tissue Engineered Collagen Biomaterials Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

組織工程膠原蛋白生物材料市場預計將從 2025 年的 35 億美元成長到 2034 年的 69.1 億美元，2026 年至 2034 年的複合年成長率為 7.84%。

受再生醫學和先進創傷護理解決方案需求不斷成長的推動，全球組織工程膠原蛋白生物材料市場正穩步成長。膠原蛋白基生物材料因其良好的生物相容性和天然癒合特性，被廣泛應用於組織修復、整形外科治療和美容手術。慢性傷口、運動傷害和老齡化相關疾病病例的增加，進一步推動了全球對創新膠原蛋白基產品的需求。

關鍵成長要素包括組織工程技術的進步和人們對微創手術日益成長的興趣。醫療機構正在擴大膠原蛋白支架和植入的使用，以改善患者的復健效果。此外，新興國家對生物醫學研究投入的增加和醫療基礎設施的擴張也為市場發展提供了支持。

未來，隨著3D生物列印技術和個人化醫療的進步，市場預計將進一步擴張。加強研究機構與生技公司之間的合作有望催生新的產品創新。在再生醫學日益受到關注的背景下，膠原蛋白生物材料有望在下一代醫學中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球組織工程膠原蛋白生物材料市場：依產品類型分類

  • 市場分析、洞察與預測
  • 水凝膠
  • 鷹架
  • 座位
  • 其他

第5章 全球組織工程膠原蛋白生物材料市場：依應用領域分類

  • 市場分析、洞察與預測
  • 整形外科
  • 循環系統
  • 皮膚和創傷護理
  • 牙科
  • 其他

第6章 全球組織工程膠原蛋白生物材料市場：依原料分類

  • 市場分析、洞察與預測
  • 源自牛
  • 豬肉衍生品
  • 海洋來源
  • 其他

第7章 全球組織工程膠原蛋白生物材料市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 研究機構
  • 生技公司
  • 其他

第8章 全球組織工程膠原蛋白生物材料市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Integra LifeSciences Corporation
    • CollPlant Biotechnologies Ltd
    • Advanced BioMatrix Inc
    • Collagen Solutions Plc
    • DSM Biomedical
    • Medtronic Plc
    • Stryker Corporation
    • Organogenesis Inc
    • Allergan Plc
    • Baxter International Inc
    • Zimmer Biomet Holdings Inc
    • Johnson & Johnson
    • Smith & Nephew Plc
    • Acelity LP Inc
    • Rousselot BV
簡介目錄
Product Code: VMR112111060

The Tissue Engineered Collagen Biomaterials Market size is expected to reach USD 6.91 Billion in 2034 from USD 3.50 Billion (2025) growing at a CAGR of 7.84% during 2026-2034.

The Global Tissue Engineered Collagen Biomaterials Market is growing steadily due to increasing demand for regenerative medicine and advanced wound care solutions. Collagen-based biomaterials are widely used in tissue repair, orthopedic treatments, and cosmetic procedures because of their biocompatibility and natural healing properties. Rising cases of chronic wounds, sports injuries, and age-related conditions are fueling demand for innovative collagen-based products worldwide.

Major growth drivers include technological advancements in tissue engineering and the rising focus on minimally invasive surgical procedures. Healthcare providers are increasingly adopting collagen scaffolds and implants to enhance patient recovery outcomes. Furthermore, growing investments in biomedical research and the expansion of healthcare infrastructure in emerging economies are supporting market development.

In the future, the market is expected to expand further with advancements in 3D bioprinting and personalized medicine. Increasing collaborations between research institutes and biotechnology companies will likely lead to new product innovations. As awareness about regenerative therapies grows, collagen biomaterials are anticipated to play a crucial role in next-generation medical treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Hydrogels
  • Scaffolds
  • Sheets
  • Others

By Application

  • Orthopedic
  • Cardiovascular
  • Skin and Wound Care
  • Dental
  • Others

By Source

  • Bovine
  • Porcine
  • Marine
  • Others

By End-User

  • Hospitals
  • Research Institutes
  • Biotechnology Companies
  • Others

COMPANIES PROFILED

  • Integra LifeSciences Corporation, CollPlant Biotechnologies Ltd, Advanced BioMatrix Inc, Collagen Solutions Plc, DSM Biomedical, Medtronic plc, Stryker Corporation, Organogenesis Inc, Allergan plc, Baxter International Inc, Zimmer Biomet Holdings Inc, Johnson Johnson, Smith Nephew plc, Acelity LP Inc, Rousselot BV
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Hydrogels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Scaffolds Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Sheets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Skin and Wound Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS MARKET: BY SOURCE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Source
  • 6.2. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Porcine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Marine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Application
    • 8.2.3 By Source
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Application
    • 8.3.3 By Source
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Application
    • 8.4.3 By Source
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Application
    • 8.5.3 By Source
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Application
    • 8.6.3 By Source
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TISSUE ENGINEERED COLLAGEN BIOMATERIALS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Integra LifeSciences Corporation
    • 10.2.2 CollPlant Biotechnologies Ltd
    • 10.2.3 Advanced BioMatrix Inc
    • 10.2.4 Collagen Solutions Plc
    • 10.2.5 DSM Biomedical
    • 10.2.6 Medtronic Plc
    • 10.2.7 Stryker Corporation
    • 10.2.8 Organogenesis Inc
    • 10.2.9 Allergan Plc
    • 10.2.10 Baxter International Inc
    • 10.2.11 Zimmer Biomet Holdings Inc
    • 10.2.12 Johnson & Johnson
    • 10.2.13 Smith & Nephew Plc
    • 10.2.14 Acelity L.P. Inc
    • 10.2.15 Rousselot B.V